Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES

🇹🇿Tanzania

Country: 🇹🇿Tanzania

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: -

Website: http://www.muhas.ac.tz

Clinical Trials

Hypofractionation for Prostate Cancer in Africa: A Feasibility Study

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2025-04-30

Last Posted Date: 2025-04-30

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 182

Registration Number: NCT06950307

Locations: 🇳🇬
NSIA-LUTH Cancer Center, Lagos, Nigeria
🇿🇦
Inkosi Albert Luthuli Central Hospital, Durban, South Africa
🇹🇿
Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS

Completed

Conditions: Diabetes Mellitus
HIV Infections
Hypertension

First Posted Date: 2023-03-27

Last Posted Date: 2023-05-08

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 333

Registration Number: NCT05786703

Locations: 🇹🇿
Temeke Regional Referral Hospital, Dar Es Salaam, Tanzania

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Phase 2

Recruiting

Conditions: Uncomplicated Plasmodium Falciparum Malaria

Interventions: Drug: Artemether-lumefantrine then Artesunate amodiaquine
Drug: Artemether-lumefantrine and Amodiaquine Drug Combination
Drug: Artemether-lumefantrine

First Posted Date: 2023-03-13

Last Posted Date: 2024-12-11

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 384

Registration Number: NCT05764746

Locations: 🇹🇿
Kibindu, Bagamoyo, Dar esSalaam, Tanzania
🇹🇿
Yombo Dispensary, Bagamoyo, Yombo, Tanzania

The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy

Phase 2

Suspended

Conditions: Cardiovascular Diseases
Hiv

Interventions: Drug: aspirin enteric coated tablet 75 mg

First Posted Date: 2022-09-01

Last Posted Date: 2022-09-01

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 454

Registration Number: NCT05525156

Locations: 🇹🇿
Mwananyamala Regional Referral Hospital, Mbagala Rangi Tatu Hospital, Dar Es Salaam, Tanzania

Entrepreneurship and Beekeeping in Tanzania

Completed

Conditions: Violence, Physical

First Posted Date: 2020-10-26

Last Posted Date: 2020-11-17

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 57

Registration Number: NCT04602416

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Effect of Adiposity and Associated Local Microbial Factors on Healing and Progression of Diabetic Foot Ulcers

Recruiting

Conditions: Diabetic Foot Ulcer

First Posted Date: 2019-05-23

Last Posted Date: 2022-12-29

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 300

Registration Number: NCT03960255

Locations: 🇹🇿
Mnazi Mmoja Hospital, Zanzibar, Unguja, Tanzania
🇹🇿
Abbas Medical Center, Dar es Salam, Tanzania
🇹🇿
Muhimbili Academic Medical Center, Dar es Salam, Tanzania

and more 1 locations

"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

Phase 4

Completed

Conditions: Malaria,Falciparum

Interventions: Drug: Artemether-Lumefantrine Tab 20-120mg
Other: Placebo
Drug: Primaquine Phosphate 0.25 mg/kg

First Posted Date: 2017-08-08

Last Posted Date: 2018-03-27

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 280

Registration Number: NCT03241901

Locations: 🇹🇿
Fukayosi Dispensary, Bagamoyo, Pwani, Tanzania
🇹🇿
Yombo Dispensary, Bagamoyo, Yombo, Tanzania

Mobile-Directly Observed Therapy on Adherence to Hydroxyurea

Phase 2

Completed

Conditions: Sickle Cell Anaemia

Interventions: Drug: Hydroxyurea
Device: Mobile Directly Observed Therapy

First Posted Date: 2016-07-26

Last Posted Date: 2024-06-12

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 98

Registration Number: NCT02844673

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes

Phase 4

Completed

Conditions: Plasmodium Falciparum

Interventions: Drug: Primaquine (For artemether-lumefantrine+primaquine arm)
Drug: Placebo (For artemether-lumefantrine arm)

First Posted Date: 2014-03-18

Last Posted Date: 2014-12-08

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 220

Registration Number: NCT02090036

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine

Phase 4

Completed

Conditions: Instantaneous Clearance

Interventions: Drug: Artemether/lumefantrine

First Posted Date: 2013-11-28

Last Posted Date: 2014-03-18

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 45

Registration Number: NCT01998295

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy